Reversal of Platelet Inhibition in Patients Receiving Ticagrelor
Antiplatelet treatment is one of the pillars of contemporary therapy in acute coronary syndromes. It is based on dual antiplatelet therapy (DAPT) consisting of aspirin and a P2Y12 receptor inhibitor. Antiaggregatory treatment reduces ischemic events, but at cost of increased bleeding rates. As a res...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
IMR Press
2022-09-01
|
Series: | Reviews in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.imrpress.com/journal/RCM/23/9/10.31083/j.rcm2309300 |